211 related articles for article (PubMed ID: 34003820)
1. Mathematical modeling of multiple pathways in colorectal carcinogenesis using dynamical systems with Kronecker structure.
Haupt S; Zeilmann A; Ahadova A; Bläker H; von Knebel Doeberitz M; Kloor M; Heuveline V
PLoS Comput Biol; 2021 May; 17(5):e1008970. PubMed ID: 34003820
[TBL] [Abstract][Full Text] [Related]
2. Three molecular pathways model colorectal carcinogenesis in Lynch syndrome.
Ahadova A; Gallon R; Gebert J; Ballhausen A; Endris V; Kirchner M; Stenzinger A; Burn J; von Knebel Doeberitz M; Bläker H; Kloor M
Int J Cancer; 2018 Jul; 143(1):139-150. PubMed ID: 29424427
[TBL] [Abstract][Full Text] [Related]
3. The coding microsatellite mutation profile of PMS2-deficient colorectal cancer.
Bajwa-Ten Broeke SW; Ballhausen A; Ahadova A; Suerink M; Bohaumilitzky L; Seidler F; Morreau H; van Wezel T; Krzykalla J; Benner A; de Miranda NF; von Knebel Doeberitz M; Nielsen M; Kloor M
Exp Mol Pathol; 2021 Oct; 122():104668. PubMed ID: 34302852
[TBL] [Abstract][Full Text] [Related]
4. Next-generation sequencing reveals heterogeneous genetic alterations in key signaling pathways of mismatch repair deficient colorectal carcinomas.
Wang J; Li R; He Y; Yi Y; Wu H; Liang Z
Mod Pathol; 2020 Dec; 33(12):2591-2601. PubMed ID: 32620917
[TBL] [Abstract][Full Text] [Related]
5. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S
J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145
[TBL] [Abstract][Full Text] [Related]
6. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.
Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ;
Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173
[TBL] [Abstract][Full Text] [Related]
7. Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer.
Li Y; Fan L; Zheng J; Nie X; Sun Y; Feng Q; Lian S; Bai W; Cai W; Yang Y; Su B; Xi Y; Lin D
Cancer Biol Med; 2022 Jun; 19(8):1235-48. PubMed ID: 35638907
[TBL] [Abstract][Full Text] [Related]
8. The diverse molecular profiles of lynch syndrome-associated colorectal cancers are (highly) dependent on underlying germline mismatch repair mutations.
Helderman NC; Bajwa-Ten Broeke SW; Morreau H; Suerink M; Terlouw D; van der Werf-' T Lam AS; van Wezel T; Nielsen M
Crit Rev Oncol Hematol; 2021 Jul; 163():103338. PubMed ID: 34044097
[TBL] [Abstract][Full Text] [Related]
9. Discordant DNA mismatch repair protein status between synchronous or metachronous gastrointestinal carcinomas: frequency, patterns, and molecular etiologies.
Vyas M; Firat C; Hechtman JF; Weiser MR; Yaeger R; Vanderbilt C; Benhamida JK; Keshinro A; Zhang L; Ntiamoah P; Gonzalez M; Andrade R; El Dika I; Markowitz AJ; Smith JJ; Garcia-Aguilar J; Vakiani E; Klimstra DS; Stadler ZK; Shia J
Fam Cancer; 2021 Jul; 20(3):201-213. PubMed ID: 33033905
[TBL] [Abstract][Full Text] [Related]
10. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
Carethers JM; Stoffel EM
World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
[TBL] [Abstract][Full Text] [Related]
11. Histology of colorectal adenocarcinoma with double somatic mismatch-repair mutations is indistinguishable from those caused by Lynch syndrome.
Hemminger JA; Pearlman R; Haraldsdottir S; Knight D; Jonasson JG; Pritchard CC; Hampel H; Frankel WL
Hum Pathol; 2018 Aug; 78():125-130. PubMed ID: 29723603
[TBL] [Abstract][Full Text] [Related]
12. Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts.
Buchanan DD; Clendenning M; Rosty C; Eriksen SV; Walsh MD; Walters RJ; Thibodeau SN; Stewart J; Preston S; Win AK; Flander L; Ouakrim DA; Macrae FA; Boussioutas A; Winship IM; Giles GG; Hopper JL; Southey MC; English D; Jenkins MA
J Gastroenterol Hepatol; 2017 Feb; 32(2):427-438. PubMed ID: 27273229
[TBL] [Abstract][Full Text] [Related]
13. Lynch-like syndrome: characterization and comparison with EPCAM deletion carriers.
Kang SY; Park CK; Chang DK; Kim JW; Son HJ; Cho YB; Yun SH; Kim HC; Kwon M; Kim KM
Int J Cancer; 2015 Apr; 136(7):1568-78. PubMed ID: 25110875
[TBL] [Abstract][Full Text] [Related]
14. From Genetics to Histomolecular Characterization: An Insight into Colorectal Carcinogenesis in Lynch Syndrome.
Lepore Signorile M; Disciglio V; Di Carlo G; Pisani A; Simone C; Ingravallo G
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201893
[TBL] [Abstract][Full Text] [Related]
15. Does breast carcinoma belong to the Lynch syndrome tumor spectrum? - Somatic mutational profiles vs. ovarian and colorectal carcinomas.
Porkka NK; Olkinuora A; Kuopio T; Ahtiainen M; Eldfors S; Almusa H; Mecklin JP; Peltomäki P
Oncotarget; 2020 Apr; 11(14):1244-1256. PubMed ID: 32292574
[TBL] [Abstract][Full Text] [Related]
16. PREMM5 distinguishes sporadic from Lynch syndrome-associated MMR-deficient/MSI-high colorectal cancer.
Sandoval RL; Horiguchi M; Ukaegbu C; Furniss CS; Uno H; Syngal S; Yurgelun MB
Fam Cancer; 2023 Oct; 22(4):459-465. PubMed ID: 37572151
[TBL] [Abstract][Full Text] [Related]
17. Mismatch repair deficiency commonly precedes adenoma formation in Lynch Syndrome-Associated colorectal tumorigenesis.
Sekine S; Mori T; Ogawa R; Tanaka M; Yoshida H; Taniguchi H; Nakajima T; Sugano K; Yoshida T; Kato M; Furukawa E; Ochiai A; Hiraoka N
Mod Pathol; 2017 Aug; 30(8):1144-1151. PubMed ID: 28548127
[TBL] [Abstract][Full Text] [Related]
18. Unexpected expression of mismatch repair protein is more commonly seen with pathogenic missense than with other mutations in Lynch syndrome.
Chen W; Hampel H; Pearlman R; Jones D; Zhao W; Alsomali M; Knight D; Frankel WL
Hum Pathol; 2020 Sep; 103():34-41. PubMed ID: 32652087
[TBL] [Abstract][Full Text] [Related]
19. Detection of DNA mismatch repair deficient crypts in random colonoscopic biopsies identifies Lynch syndrome patients.
Brand RE; Dudley B; Karloski E; Das R; Fuhrer K; Pai RK; Pai RK
Fam Cancer; 2020 Apr; 19(2):169-175. PubMed ID: 31997046
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation changes and somatic mutations as tumorigenic events in Lynch syndrome-associated adenomas retaining mismatch repair protein expression.
Mäki-Nevala S; Valo S; Ristimäki A; Sarhadi V; Knuutila S; Nyström M; Renkonen-Sinisalo L; Lepistö A; Mecklin JP; Peltomäki P
EBioMedicine; 2019 Jan; 39():280-291. PubMed ID: 30578081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
